New Results
Low-dose fluvoxamine modulates endocytic trafficking of SARS-CoV-2 spike protein: a potential mechanism for anti-COVID-19 protection by antidepressants
View ORCID ProfileOleg O Glebov
doi: https://doi.org/10.1101/2021.06.15.448391
Oleg O Glebov
Qingdao University; King’s College London
Article usage
Posted June 15, 2021.
Low-dose fluvoxamine modulates endocytic trafficking of SARS-CoV-2 spike protein: a potential mechanism for anti-COVID-19 protection by antidepressants
Oleg O Glebov
bioRxiv 2021.06.15.448391; doi: https://doi.org/10.1101/2021.06.15.448391
Subject Area
Subject Areas
- Biochemistry (11695)
- Bioengineering (8714)
- Bioinformatics (29105)
- Biophysics (14917)
- Cancer Biology (12045)
- Cell Biology (17343)
- Clinical Trials (138)
- Developmental Biology (9403)
- Ecology (14133)
- Epidemiology (2067)
- Evolutionary Biology (18256)
- Genetics (12213)
- Genomics (16752)
- Immunology (11837)
- Microbiology (27982)
- Molecular Biology (11540)
- Neuroscience (60745)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3224)
- Physiology (4933)
- Plant Biology (10379)
- Synthetic Biology (2875)
- Systems Biology (7328)
- Zoology (1640)